It is encouraging that ABZs significantly inhibited the expression of HIF-1α in non-small cell lung cancer and ovarian cancer; however, ABZ treatment did not affect the HIF-1α mRNA level, suggesting that other unknown regulatory pathways may be involved in this process (62, 63). Here, HIF1A is linked to ovarian cancer.